Variables | All patients (N = 48) | NO fibrosis (N = 29) | WITH fibrosis (N = 19) | P |
---|---|---|---|---|
Age, years (SD) | 61 (13) | 59 (11) | 65 (15) | 0.112 |
Male sex, No. (%) | 33 (69) | 18 (62.1) | 15 (78.9) | 0.217 |
BMI, kg/m2 (range) | 28.4 (19.0-56.1) | 27.0 (19.0-56.1) | 29.4 (19.5-53.5) | 0.348 |
Functional mitral regurgitation, No. (%) | 13 (27.1) | 5 (17.2) | 8 (42.1) | 0.06 |
History of diabetes mellitus, No. (%) | 7 (14.6) | 3 (10.3) | 4 (21.1) | 0.31 |
History of dyslipidemia, No. (%) | 23 (47.9) | 11 (37.9) | 12 (63.2) | 0.09 |
History of hypertension, No. (%) | 30 (62.5) | 16 (55.2) | 14 (73.7) | 0.20 |
Hemoglobin level on admission, g/dL (range) | 13 (7-16) | 13.0 (8.0-15.0) | 13.0 (7.0-16.0) | 0.574 |
Statins, No. (%) | 14 (29.2) | 6 (20.7) | 8 (42.1) | 0.110 |
ACEI or ARB, No. (%) | 19 (39.6) | 8 (27.6) | 11 (57.9) | 0.036 |
β blockers, No. (%) | 25 (52.1) | 12 (41.4) | 13 (68.4) | 0.067 |
Aspirin, No. (%) | 22 (45.8) | 13 (44.8) | 9 (47.4) | 0.863 |
Cardiac MRI LVEF, % (SD) | 63.04 (11.86) | 63.31 (12.34) | 62.63 (11.40) | 0.85 |
Cardiac MRI RVEF, % (SD) | 52.00 (10.33) | 52.97 (10.62) | 48.84 (9.60) | 0.18 |
Cardiac MRI LVEDV, mL (SD) | 200.00(61.34) | 199.42 (57.56) | 198.34 (68.33) | 0.95 |
Cardiac MRI LVESV, mL (SD) | 68.50 (41.03) | 75.63 (40.25) | 76.50 (43.31) | 0.94 |